Moderna Vaccine elicits immune response in infant model: study

Moderna Vaccine elicits immune response in infant model: study

Subject : Science & tech

Context : The results, published in Science Immunology, suggest that vaccines for young children are likely important, safe tools to curtail the pandemic, according to the researchers.

Concept :

• A group of scientists reported that the Moderna mRNA vaccine and a protein-based vaccine candidate elicited durable neutralising antibody responses to SARS-CoV-2 in pre-clinical research with baby rhesus macaques. There were no adverse effects
• The strong neutralising antibody responses elicited by the vaccines in 16 baby rhesus macaques persisted for 22 weeks.

mRNA 1273 :

• mRNA-1273 is the working name of Moderna’s vaccine. It is currently under the aegis of the US National Institute of Allergy and Infectious Diseases (NIAID), a part of the US National Institutes of Health (NIH).
• The mRNA means the messenger RNA. This carries the carries the genetic formula for the coding of a specific protein.
• The mRNA is a molecule that genetically encodes a set of instructions, based on which cells make proteins and send them to various parts of the body.
• Vaccines based on mRNA technology take advantage of normal biological processes of the body to create the desired therapeutic effect.